What it is
Regulatory status: Dietary supplement; not an approved anticoagulant, blood-pressure medicine or treatment for atherosclerosis.
Mechanism evidence: human
Nattokinase has fibrinolytic activity in laboratory systems and may influence coagulation or blood-pressure pathways. Small human trials report modest blood-pressure changes, but claims that capsules remove arterial plaque or prevent clots are not established clinical outcomes.
What it is, why people use it, the evidence, and what to know before trying it.
Regulatory status: Dietary supplement; not an approved anticoagulant, blood-pressure medicine or treatment for atherosclerosis.
Mechanism evidence: human
Nattokinase has limited trial evidence for a small blood-pressure reduction, but no proof that it clears arteries or prevents cardiovascular events. Because it may affect clotting, casual self-experimentation—especially alongside blood thinners—has a less favorable risk profile than marketing suggests.
Confidence: weak
Known side effects, interactions and use limits from reviewed sources.
Potential bleeding is the central concern. Avoid combining nattokinase with anticoagulants, antiplatelet drugs or before surgery unless a clinician specifically approves it. Soy allergy, pregnancy, bleeding disorders and prior hemorrhagic stroke require particular caution.
Public protocols that include Nattokinase. Open one to see the full context and source.
Reviewed dose and timing context, separate from what public protocols report.
Continue into interventions that appear alongside this one.